Exchange: NASDAQ·Updated 07:56 PM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 03

Estimated EPS

$4.74

Reported EPS

$4.73

Surprise

-0.23%

Estimated Rev

$3.23B

Reported Rev

$3.33B

Surprise

+3.25%

$VRTX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $4.34 up 7.96% YoY • Reported revenue of $3.33B up 12.45% YoY • Vertex Pharmaceuticals raised its full year 2026 total revenue guidance to $13.1 billion to $13.2 billion, while reiterating guidance for combined GAAP and non-GAAP R&D, AIPR&D, and SG&A expenses.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$4.80
--
--
N/A
Q2 '26
$4.74
$4.73
-0.23%
MISSED
Q1 '26
$4.24
$4.47
5.35%
BEAT
Q4 '25
$5.11
$5.03
-1.58%
MISSED
Q3 '25
$4.58
$4.80
4.91%
BEAT

Advertisement|Remove ads.